Low PD-L1 expression, MAP2K2 alterations, and enriched HPV gene signatures characterize brain metastases in head and neck squamous cell carcinoma.

Autor: Dennis MJ; Center for Head & Neck Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Michael_dennis@dfci.harvard.edu.; Dana-Farber Cancer Institute, 450 Brookline Avenue, Dana Building, Room 2128, Boston, MA, 02215, USA. Michael_dennis@dfci.harvard.edu., Pavlick DC; Foundation Medicine Inc., Boston, MA, USA., Kacew A; Pritzker School of Medicine, The University of Chicago, Chicago, IL, USA., Wotman M; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., MacConaill LE; Department of Pathology, Mass General Brigham, Boston, MA, USA., Jones SM; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Pfaff KL; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Rodig SJ; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Eacker S; Phase Genomics Inc., Seattle, WA, USA., Malig M; Phase Genomics Inc., Seattle, WA, USA., Reister E; Phase Genomics Inc., Seattle, WA, USA., Piccioni D; Moores Cancer Center, University of California San Diego Health, La Jolla, CA, USA., Kesari S; Pacific Neuroscience Institute, Santa Monica, CA, USA., Sehgal K; Center for Head & Neck Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Haddad RI; Center for Head & Neck Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Cohen E; Moores Cancer Center, University of California San Diego Health, La Jolla, CA, USA., Posner MR; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Deichaite I; University of California San Diego, La Jolla, CA, USA., Hanna GJ; Center for Head & Neck Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

Publikováno v: Journal of translational medicine [J Transl Med] 2024 Oct 22; Vol. 22 (1), pp. 960. Date of Electronic Publication: 2024 Oct 22.

Acetabular coverage exerts minimal influence on femoral head collapse and the necessity for surgical intervention in patients with osteonecrosis of femoral head.

Autor: Kuriyama Y; Department of Orthopaedic Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan., Tanaka H; Department of Orthopaedic Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan. hidetatsu.tanaka.c7@tohoku.ac.jp., Baba K; Department of Orthopaedic Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan., Kanabuchi R; Department of Orthopaedic Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan., Mori Y; Department of Orthopaedic Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan., Aizawa T; Department of Orthopaedic Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.

Publikováno v: International orthopaedics [Int Orthop] 2024 Sep; Vol. 48 (9), pp. 2331-2337. Date of Electronic Publication: 2024 Jun 20.

Prognostic Value of the ¹⁸ F-FDG PET/CT and Haematological Parameters in Head and Neck Cancer.

Autor: Wakisaka R; Department of Otolaryngology - Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan., Kumai T; Department of Otolaryngology - Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan.; Department of Innovative Head & Neck Cancer Research and Treatment (IHNCRT), Asahikawa Medical University, Asahikawa, Japan., Komatsuda H; Department of Otolaryngology - Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan., Yamaki H; Department of Otolaryngology - Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan., Kono M; Department of Otolaryngology - Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan., Sato R; Department of Otolaryngology - Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan., Ohara K; Department of Otolaryngology - Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan., Kishibe K; Department of Otolaryngology - Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan., Hayashi T; Department of Otolaryngology - Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan., Okizaki A; Department of Radiology, Asahikawa Medical University, Asahikawa, Japan., Takahara M; Department of Otolaryngology - Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan.; Department of Innovative Head & Neck Cancer Research and Treatment (IHNCRT), Asahikawa Medical University, Asahikawa, Japan.

Publikováno v: Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery [Clin Otolaryngol] 2024 Nov; Vol. 49 (6), pp. 733-741. Date of Electronic Publication: 2024 Jul 01.

Factors Associated with Head and Neck Cancer Postoperative Radiotherapy Delays: A Systematic Review and Meta-analysis.

Autor: Duckett KA; Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USA., Kassir MF; Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USA., Nguyen SA; Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USA., Brennan EA; MUSC Libraries, Medical University of South Carolina, Charleston, South Carolina, USA., Chera BS; Department of Radiation Oncology, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA., Sterba KR; Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA., Halbert CH; Department of Population and Public Health Sciences, University of Southern California, Los Angeles, California, USA., Hill EG; Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA., McCay J; Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USA., Puram SV; Department of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine, St Louis, Missouri, USA.; Department of Genetics, Washington University School of Medicine, St Louis, Missouri, USA., Jackson RS; Department of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine, St Louis, Missouri, USA., Sandulache VC; Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas, USA.; ENT Section, Operative CareLine, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA., Kahmke R; Department of Head and Neck Surgery and Communication Sciences, Duke University, Durham, North Carolina, USA., Osazuwa-Peters N; Department of Head and Neck Surgery and Communication Sciences, Duke University, Durham, North Carolina, USA.; Department of Population Health Sciences, School of Medicine, Duke University, Durham, North Carolina, USA., Ramadan S; Department of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine, St Louis, Missouri, USA., Nussenbaum B; American Board of Otolaryngology-Head and Neck Surgery, Houston, Texas, USA., Alberg AJ; Department of Epidemiology and Biostatistics, University of South Carolina Arnold School of Public Health, Columbia, South Carolina, USA., Graboyes EM; Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.; Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.

Publikováno v: Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery [Otolaryngol Head Neck Surg] 2024 Nov; Vol. 171 (5), pp. 1265-1282. Date of Electronic Publication: 2024 Jun 06.

Alum-anchored IL-12 combined with cytotoxic chemotherapy and immune checkpoint blockade enhanced antitumor immune responses in head and neck cancer models.

Autor: Fabian KP; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Santiago-Sanchez G; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Padget MR; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Lassoued W; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Allen CT; Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Battula S; Ankyra Therapeutics, Cambridge, Massachusetts, USA., Kaufman H; Ankyra Therapeutics, Cambridge, Massachusetts, USA., Hodge JW; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA jh241d@nih.gov.

Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Oct 23; Vol. 12 (10). Date of Electronic Publication: 2024 Oct 23.